Breaking News: Sarepta's gene therapy strikes again, claiming another 'volunteer' in its relentless quest for liver failure supremacy! 🎯✨ Who knew gene therapy could double as a population control experiment? 🤷‍♂️💀
https://www.biocentury.com/article/656520/third-death-from-a-sarepta-gene-therapy #SareptaGeneTherapy #LiverFailure #BreakingNews #PopulationControl #MedicalEthics #HackerNews #ngated
Third death from a Sarepta gene therapy

A third patient, a 51 year-old in a Phase I study of SRP-9004 for Limb-Girdle muscular dystrophy Type 2E, has died from a Sarepta gene therapy.Like two dea...

Biocentury
Third death from a Sarepta gene therapy

A third patient, a 51 year-old in a Phase I study of SRP-9004 for Limb-Girdle muscular dystrophy Type 2E, has died from a Sarepta gene therapy.Like two dea...

Biocentury